tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid

C105H112N14O13 — CID 161217694

IUPACtert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid
SMILESCC(=O)c1cnc2nc(-c3ccccc3)c(CCCCC(=O)OC(C)(C)C)nc2c1.CC(C)(C)OC(=O)CCCCc1nc2cc(C(=O)O)cnc2nc1-c1ccccc1.Cc1ccc(CNC(=O)c2cnc3nc(-c4ccccc4)c(CCCCC(=O)O)nc3c2)cc1.Cc1ccc(CNC(=O)c2cnc3nc(-c4ccccc4)c(CCCCC(=O)OC(C)(C)C)nc3c2)cc1
InChIInChI=1S/C31H34N4O3.C27H26N4O3.C24H27N3O3.C23H25N3O4/c1-21-14-16-22(17-15-21)19-33-30(37)24-18-26-29(32-20-24)35-28(23-10-6-5-7-11-23)25(34-26)12-8-9-13-27(36)38-31(2,3)4;1-18-11-13-19(14-12-18)16-29-27(34)21-15-23-26(28-17-21)31-25(20-7-3-2-4-8-20)22(30-23)9-5-6-10-24(32)33;1-16(28)18-14-20-23(25-15-18)27-22(17-10-6-5-7-11-17)19(26-20)12-8-9-13-21(29)30-24(2,3)4;1-23(2,3)30-19(27)12-8-7-11-17-20(15-9-5-4-6-10-15)26-21-18(25-17)13-16(14-24-21)22(28)29/h5-7,10-11,14-18,20H,8-9,12-13,19H2,1-4H3,(H,33,37);2-4,7-8,11-15,17H,5-6,9-10,16H2,1H3,(H,29,34)(H,32,33);5-7,10-11,14-15H,8-9,12-13H2,1-4H3;4-6,9-10,13-14H,7-8,11-12H2,1-3H3,(H,28,29)
InChIKeyUXBYSWMBBKZLEE-UHFFFAOYSA-N
MW1778.14 g/mol
LogP20.11
Rot. Bonds32

About tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid

tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid (PubChem CID 161217694) has the molecular formula C105H112N14O13 and a molecular weight of 1778.14 g/mol. Its IUPAC name is tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid.

Molecular Properties

Compound Nametert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid
PubChem CID161217694
Molecular FormulaC105H112N14O13
Molecular Weight1778.14 g/mol
Exact Mass1776.85
IUPAC Nametert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid
SMILESCC(=O)c1cnc2nc(-c3ccccc3)c(CCCCC(=O)OC(C)(C)C)nc2c1.CC(C)(C)OC(=O)CCCCc1nc2cc(C(=O)O)cnc2nc1-c1ccccc1.Cc1ccc(CNC(=O)c2cnc3nc(-c4ccccc4)c(CCCCC(=O)O)nc3c2)cc1.Cc1ccc(CNC(=O)c2cnc3nc(-c4ccccc4)c(CCCCC(=O)OC(C)(C)C)nc3c2)cc1
InChIInChI=1S/C31H34N4O3.C27H26N4O3.C24H27N3O3.C23H25N3O4/c1-21-14-16-22(17-15-21)19-33-30(37)24-18-26-29(32-20-24)35-28(23-10-6-5-7-11-23)25(34-26)12-8-9-13-27(36)38-31(2,3)4;1-18-11-13-19(14-12-18)16-29-27(34)21-15-23-26(28-17-21)31-25(20-7-3-2-4-8-20)22(30-23)9-5-6-10-24(32)33;1-16(28)18-14-20-23(25-15-18)27-22(17-10-6-5-7-11-17)19(26-20)12-8-9-13-21(29)30-24(2,3)4;1-23(2,3)30-19(27)12-8-7-11-17-20(15-9-5-4-6-10-15)26-21-18(25-17)13-16(14-24-21)22(28)29/h5-7,10-11,14-18,20H,8-9,12-13,19H2,1-4H3,(H,33,37);2-4,7-8,11-15,17H,5-6,9-10,16H2,1H3,(H,29,34)(H,32,33);5-7,10-11,14-15H,8-9,12-13H2,1-4H3;4-6,9-10,13-14H,7-8,11-12H2,1-3H3,(H,28,29)
InChIKeyUXBYSWMBBKZLEE-UHFFFAOYSA-N
XLogP20.11
TPSA383.45 Ų
H-Bond Donors4
H-Bond Acceptors23
Rotatable Bonds32
Heavy Atoms132
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001778.14
LogP ≤ 520.11
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid?
The IUPAC name of tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid (CID 161217694) is tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid.
What is the SMILES notation for tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid?
The canonical SMILES for tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid is CC(=O)c1cnc2nc(-c3ccccc3)c(CCCCC(=O)OC(C)(C)C)nc2c1.CC(C)(C)OC(=O)CCCCc1nc2cc(C(=O)O)cnc2nc1-c1ccccc1.Cc1ccc(CNC(=O)c2cnc3nc(-c4ccccc4)c(CCCCC(=O)O)nc3c2)cc1.Cc1ccc(CNC(=O)c2cnc3nc(-c4ccccc4)c(CCCCC(=O)OC(C)(C)C)nc3c2)cc1.
What is the InChIKey of tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid?
The InChIKey is UXBYSWMBBKZLEE-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H34N4O3.C27H26N4O3.C24H27N3O3.C23H25N3O4/c1-21-14-16-22(17-15-21)19-33-30(37)24-18-26-29(32-20-24)35-28(23-10-6-5-7-11-23)25(34-26)12-8-9-13-27(36)38-31(2,3)4;1-18-11-13-19(14-12-18)16-29-27(34)21-15-23-26(28-17-21)31-25(20-7-3-2-4-8-20)22(30-23)9-5-6-10-24(32)33;1-16(28)18-14-20-23(25-15-18)27-22(17-10-6-5-7-11-17)19(26-20)12-8-9-13-21(29)30-24(2,3)4;1-23(2,3)30-19(27)12-8-7-11-17-20(15-9-5-4-6-10-15)26-21-18(25-17)13-16(14-24-21)22(28)29/h5-7,10-11,14-18,20H,8-9,12-13,19H2,1-4H3,(H,33,37);2-4,7-8,11-15,17H,5-6,9-10,16H2,1H3,(H,29,34)(H,32,33);5-7,10-11,14-15H,8-9,12-13H2,1-4H3;4-6,9-10,13-14H,7-8,11-12H2,1-3H3,(H,28,29).
What are the key properties of tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid?
tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid has a molecular weight of 1778.14 g/mol, XLogP of 20.11, 32 rotatable bonds, 4 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl 5-(7-acetyl-3-phenylpyrido[2,3-b]pyrazin-2-yl)pentanoate;tert-butyl 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoate;5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid;2-[5-[(2-methylpropan-2-yl)oxy]-5-oxopentyl]-3-phenylpyrido[2,3-b]pyrazine-7-carboxylic acid is sourced from PubChem (CID 161217694), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).